DIR 020 and DIR 021 annual reports
DIR-108 annual report
Correspondence about a query on the regulation of null segregants, topics for a presentation
and publishing a presentation provided by the OGTR.
This letter lays out the Minister's expectations of the Gene Technology Regulator.
Accredited organisations must tell the Gene Technology Regulator within 30 days about changes to organisation contacts, authorised persons and IBC contacts.
These documents support the Risk Assessment and Risk Management Plans (RARMPs) prepared for applications for dealings involving intentional release (DIRs) of GMOs into the environment. They address matters common to many DIR risk assessments and are referred to in relevant RARMPs.
Gene Technology (Equine Influenza Vaccine) Emergency Dealing Extension Determination 2008
This impact statement assesses the changes recommended by the 2016-19 Technical Review of the Gene Technology Regulations.
The Gene Technology Act 2000 requires Gene Technology Regulator to report annually on their operations. The reports are produced for the Minister as soon as practicable after the end of each financial year.
Our service charter details our commitment to providing quality services to the public and users of Australia’s scheme for gene regulation. It also outlines what to do when we do not meet the charter.